Relevant bibliographies by topics / Hepatitis C virus – New South Wales

Academic literature on the topic 'Hepatitis C virus – New South Wales'

Author: Grafiati
Published: 4 June 2021
Last updated: 9 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatitis C virus – New South Wales.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatitis C virus – New South Wales"

1

Butler, T., B. Donovan, J. Taylor, A. L. Cunningham, A. Mindel, M. Levy, and J. Kaldor. "Herpes simplex virus type 2 in prisoners, New South Wales, Australia." International Journal of STD & AIDS 11, no. 11 (November 1, 2000): 743–47. http://dx.doi.org/10.1258/0956462001915174.

Full text
Abstract:
Our objectives were to determine the prevalence of, and risk factors for, herpes simplex virus type 2 (HSV-2) antibodies in male and female prisoners. A cross-sectional random sample was used consisting of 789 prisoners (657 males and 132 females) from 27 correctional centres across New South Wales (NSW), stratified by sex, age and Aboriginality. Participants were questioned about demographics and behavioural risk factors and were screened for serum antibody to HSV-2. The overall prevalence of HSV-2 antibodies was higher in females (58%) than males (21%), and in Aborigines (34%) compared with non-Aborigines (24%). HSV-2 prevalence increased with the number of sexual partners. Few prisoners (1%) reported a previous diagnosis of genital herpes. Independent risk factors for the presence of HSV-2 antibodies were increasing age and Aboriginality for men, and higher reported number of lifetime sexual partners and the presence of hepatitis C antibodies for women. HSV-2 infection is common in prison inmates. There is a need to incorporate information about STDs, including HSV-2, into education programmes for inmates.
APA, Harvard, Vancouver, ISO, and other styles
2

Hajarizadeh, B., J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, et al. "Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study." Journal of Hepatology 68 (April 2018): S187—S188. http://dx.doi.org/10.1016/s0168-8278(18)30587-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Grebely, J., J. Bryant, P. Hull, M. Hopwood, Y. Lavis, G. J. Dore, and C. Treloar. "Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia." Journal of Viral Hepatitis 18, no. 4 (September 14, 2010): e104-e116. http://dx.doi.org/10.1111/j.1365-2893.2010.01370.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hajarizadeh, B., J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, et al. "Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study." Journal of Hepatology 66, no. 1 (2017): S274. http://dx.doi.org/10.1016/s0168-8278(17)30862-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hajarizadeh, B., J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, et al. "O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study." Journal of Virus Eradication 3 (August 2017): 2–3. http://dx.doi.org/10.1016/s2055-6640(20)30889-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gunasekera, Sanjeevani, John Fraser, and Christian Alexander. "Quality of life in Hepatitis C virus infection: Assessment of rural patients living in north-western New South Wales." Australian Journal of Rural Health 16, no. 4 (August 2008): 213–20. http://dx.doi.org/10.1111/j.1440-1584.2008.00983.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bretaña, Neil A., Richard R. Gray, Evan B. Cunningham, Brigid Betz‐Stablein, Ruy Ribeiro, Frederik Graw, Fabio Luciani, and Andrew R. Lloyd. "Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study." Addiction 115, no. 5 (May 2020): 901–13. http://dx.doi.org/10.1111/add.14830.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alavi, Maryam, Matthew G. Law, Heather Valerio, Jason Grebely, Janaki Amin, Behzad Hajarizadeh, Christine Selvey, Jacob George, and Gregory J. Dore. "Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia." Journal of Hepatology 71, no. 2 (August 2019): 281–88. http://dx.doi.org/10.1016/j.jhep.2019.04.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

GIDDING, H. F., J. AMIN, G. J. DORE, and M. G. LAW. "Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C." Epidemiology and Infection 139, no. 8 (November 19, 2010): 1151–58. http://dx.doi.org/10.1017/s095026881000258x.

Full text
Abstract:
SUMMARYTo determine the extent age, sex and co-infection affect morbidity in people infected with hepatitis C virus (HCV), we performed a population-based study linking HCV notifications in New South Wales, Australia with their hospital (July 2000 to June 2006), hepatitis B virus (HBV) and HIV notification, and death records. Poisson models were used to calculate hospitalization rate ratios (RRs) for all-cause, illicit drug and liver-related admissions. Co-infection RRs were used to estimate attributable risk (AR). The 86 501 people notified with HCV contributed 422 761 person-years of observation; 0·8% had HIV, 3·7% HBV, and 0·04% had both. RRs for males were equal to or lower than for females in younger ages, but higher in older ages (Pfor interaction ⩽0·013). HBV/HIV co-infection resulted in ARs of over 70% for liver disease and 30–60% otherwise. However, at the cohort level the impact was minimal (population ARs 1·3–8·7%). Our findings highlight the importance and success of public health measures, such as needle and syringe exchange programmes, which have helped to minimize the prevalence of co-infection in Australia. The findings also suggest that the age of study participants needs to be considered whenever the burden of HCV-related morbidity is reported by sex. The results are likely to be representative of patterns in hospital-related morbidity for the entire HCV-infected population in Australia and the ARs generalizable to other developed countries.
APA, Harvard, Vancouver, ISO, and other styles
10

Fortier, Emmanuel, Maryam Alavi, Julie Bruneau, Michelle Micallef, Jacinta Perram, Sanjeev Sockalingam, Adrian J. Dunlop, et al. "Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia." Journal of Addiction Medicine 11, no. 1 (2017): 10–18. http://dx.doi.org/10.1097/adm.0000000000000261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatitis C virus – New South Wales"

1

Amin, Janaki Public Health &amp Community Medicine Faculty of Medicine UNSW. "Hepatitis B and C associated cancer and mortality: New South Wales, 1990-2002." Awarded by:University of New South Wales. School of Public Health and Community Medicine, 2006. http://handle.unsw.edu.au/1959.4/27338.

Full text
Abstract:
This thesis examines cancer and mortality rates among people diagnosed with hepatitis B (HBV) and C (HCV) infection in New South Wales (NSW) from 1990 through 2002, by linking hepatitis notifications with the NSW Central Cancer Registry (CCR) and National Death Index. Of the 39101 HBV, 75834 HCV and 2604 HBV/HCV co-infection notifications included 1052, 1761 and 85 were linked to cancer notifications and 1233, 4008 and 186 were linked to death notifications respectively. Of 2072 hepatocellular carcinoma (HCC) notifications to the CCR 323, 267 and 85 were linked to HBV, HCV and HBV/HCV co-infection notifications. Incidence of HCC was 6.5, 4.0 and 5.9 per 1000 person years for HBV, HCV and HBV/HCV co-infected groups. Risk of HCC in those diagnosed with hepatitis was 20 to 30 times greater than the standard population. There was a marginally statistically significant increased risk of immunoproliferative malignancies associated with HCV infection (SIR=5.6 95% CI 1.8 ???17.5). Risk of death for those with hepatitis was significantly greater, 1.5 to 5 fold, than the general population with the greatest risk among those with HBV/HCV co-infection. The primary cause of HBV deaths was liver related, particularly HCC, whereas in the HCV groups drug related deaths were most frequent. Among people with HCV, risk of dying from drug related causes was significantly greater than from liver related causes (p=0.012), with the greatest increased risk in females age 15- 24 years (SMR 56.9, 95%CI 39.2???79.9). Median age at diagnosis of HCC varied markedly by country of birth and hepatitis group: HBV 66, 63 and 57years ; HCV 51, 68 and 71 years; unlinked 69, 70 and 64 years for Australian, European, and Asian-born groups, respectively (P<0.0001 for all groups). While the risk of cancer, particularly HCC, is elevated among people with HBV and HCV infection, the absolute risk remains low. Young people with HCV face a higher mortality risk from continued drug use than from liver damage related to their HCV infection. The influence of IDU in the epidemiology of HCC in New South Wales was possibly reflected in the varying distributions of age and country of birth.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hepatitis C virus – New South Wales' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography